● 1Q 2022 PBT increased by 15% to RM26.65 million compared to previous corresponding quarter
● Revenue gained 12% to RM185.94 million year-on-year
● Improving Malaysian economy, recovery in domestic demand bode well for Duopharma Biotech’s prospects
Kuala Lumpur, February 25 2022 – Uphamol, the leading paracetamol brand from Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) is now the Official Partner for the Malaysian Football League (MFL) in the Analgesic Category for a two-year period from 1 January 2022 to 31 December 2023, as part of a sponsorship agreement with Duopharma Biotech during this period. The sponsorship agreement will cover the Perlawanan Sumbangsih, Liga Super and Piala Malaysia competitions in 2022 and 2023 respectively.
KUALA LUMPUR, 25 FEBRUARY 2022 – Proviton STR, a leading isotonic drink brand from Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) has signed on as the new Official Partner for the Malaysian Football League (MFL) in the Isotonic category, as part of a two-year MFL sponsorship by Duopharma Biotech, from 1 January 2022 to 31 December 2023. The sponsorship will cover the Perlawanan Sumbangsih, Liga Super and Piala Malaysia competitions in 2022 and 2023 respectively.
● 4Q revenue grows 8.5% to RM145.44 million compared to previous corresponding quarter
● Second interim dividend of 1.8 sen per share
● New and extended public sector supply contracts, potential tax savings to bolster future earnings
